Reichert, Hannah
University of Iowa Health Care
2 papers on CoChat
Most cited papers
- Verified
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Russell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet
Retinal Development and DisordersVirus-based gene therapy research
Cited by 1,952
- Verified
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy
Maguire, A. M., Russell, S., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., Marshall, K. A., et al. (2019) · Ophthalmology
Retinal Development and DisordersVirus-based gene therapy research
Cited by 409
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free